NRA-BILASTINE
NRA-BILASTINE
Approved
DIN Number
02551934
Drug Class
Human
Market Date
Oct 30, 2024
Company
HC
nora pharma inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02551934
AIG Number0158051001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R06AX29 BILASTINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification04:08.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BILASTINEActive
Strength: 20 MG
Monograph: BILASTINE